Italy's Chiesi Group has revealed plans to spend €430 million ($464 million) on a new therapeutics manufacturing facility at ...
A shuttered Milanese manufacturing site with a storied history is getting a new lease on life, thanks to a nearly ...
Chiesi plans Milan factory, Bharat Biotech builds CGT site, Aspen faces FDA warning, Currax adds Contrave site, Redwire aids ...
Chiesi Group, a global biopharmaceutical company headquartered in Parma, Italy, has announced a major investment in Nerviano (Milan, Italy), with the construction of a new facility for the production ...
An advance in biologics for Chiesi; an advancement for Italy as a whole Son of founder Giacomo Chiesi himself, Alberto Chiesi opened the occasion. The purpose behind this new Biotech Centre of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results